Spike and Local Field Synchronization Between the Pedunculopontine Nucleus and Primary Motor Cortex in a Rat Model of Parkinson's Disease

Neuroscience. 2019 Apr 15:404:470-483. doi: 10.1016/j.neuroscience.2019.01.044. Epub 2019 Jan 31.

Abstract

The pedunculopontine nucleus (PPN) shows altered electrophysiological and anatomic characteristics in Parkinson's disease (PD), but little is known about the effect of 6-hydroxydopamine (6-OHDA) lesion and levodopa (L-DOPA) therapy on the relationship between spike and local field potential (LFP) activities in the PPN and motor cortex. Aiming to investigate this, synchronous spike and LFP signals in the PPN and primary motor cortex (M1) were recorded. The spike-LFP relationship was evaluated using coherence analysis, phase-lock and spike-field coherence (SFC). The results suggested that 6-OHDA lesion had a significant effect on the spike-LFP relationship between the PPN and M1 in rats under a rest or locomotion state. The significantly altered frequency bands varied across different neuron types and animal activity states. In addition, the altered coherence values between PPN spike and M1 LFP were refractory to long-term L-DOPA therapy although all other changes could be reversed by this drug treatment. All results provided evidence of the spike-LFP relationship between the PPN and M1 in PD, revealing some network mechanisms of the cortico-basal ganglia circuitry and PPN, which might be an underlying candidate for PD pathophysiology and therapy.

Keywords: Parkinson's disease; coherence; local field potential; motor cortex; spike; the pedunculopontine nucleus.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Action Potentials / drug effects
  • Action Potentials / physiology*
  • Animals
  • Disease Models, Animal*
  • Levodopa / pharmacology
  • Levodopa / therapeutic use
  • Male
  • Motor Cortex / drug effects
  • Motor Cortex / physiology*
  • Oxidopamine / toxicity
  • Parkinsonian Disorders / chemically induced*
  • Parkinsonian Disorders / drug therapy
  • Parkinsonian Disorders / physiopathology*
  • Pedunculopontine Tegmental Nucleus / drug effects
  • Pedunculopontine Tegmental Nucleus / physiology*
  • Rats
  • Rats, Wistar

Substances

  • Levodopa
  • Oxidopamine